Anika Therapeutics
Price & Volume
Stats
See moreOpen | $14.93 |
Previous Close | $14.76 |
Day Range | $14.70-$15.01 |
52W Range | $7.87-$15.47 |
Market Cap | $212.8M |
Shares Short | 688,325 |
Financials
See moreRevenue (12 Mos) | $112.8M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $63.8M |
Diluted EPS | -$0.70 |
News
See moreYahoo Finance • 5 days ago
Telix Strengthens Board with Additional Director Appointments
Yahoo Finance • 6 days ago
Revance CEO Nadeem Moiz on Expansion, Opportunities & Capitalization
Yahoo Finance • 10 days ago
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 2 months ago
Anika Therapeutics Q4 Earnings Call Highlights
About
CEO | Mr. Stephen D. Griffin |
Address | 32 Wiggins Avenue, Bedford, MA, United States, 01730 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 235 |
